Bilal Bashir, See Kwok, Anthony S Wierzbicki, Alan Jones, Charlotte Dawson, Paul Downie, Fiona Jenkinson, Hannah Delaney, Michael Mansfield, Dev Datta, Yee Teoh, Paul Hamilton, Natalie Forrester, Dawn O'Sullivan, Maryam Ferdousi, Paul N Durrington, Alaa AbdelRazik, Antonio Gallo, Philippe Moulin, Handrean Soran
BACKGROUND AND AIMS: Prognosis and management differ between familial chylomicronaemia syndrome (FCS), a rare autosomal recessive disorder, and multifactorial chylomicronaemia syndrome (MCS) or severe mixed hyperlipidaemia. A clinical scoring tool to differentiate these conditions has been devised but not been validated in other populations. The objective of this study was to validate this score in the UK population and identify any additional factors that might improve it. METHODS: A retrospective validation study was conducted using data from 151 patients comprising 75 FCS and 76 MCS patients...
February 10, 2024: Atherosclerosis